PDS Biotechnology
Price & Volume
Stats
See moreOpen | $1.01 |
Previous Close | $1.01 |
Day Range | $1.01-$1.01 |
52W Range | $0.85-$4.29 |
Market Cap | $47.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.91 |
News
See moreYahoo Finance • 13 days ago
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1–19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population
Yahoo Finance • last month
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
Yahoo Finance • 2 months ago
Earnings call transcript: PDS Biotech Q2 2025 reports narrower EPS loss, stock rises
Yahoo Finance • 2 months ago
PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) Reports Narrower Q2 2025 Loss, Stock Rises on Clinical Progress
About
CEO | Dr. Frank K. Bedu-Addo Ph.D. |
CFO | Mr. Lars Robert Boesgaard M.B.A. |
Address | 303A College Road East, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |
